Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 332 of 1,261
  1. US 11046769

    Multispecific binding constructs against checkpoint molecules and uses thereof

    Compass Therapeutics LLC · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  2. US 11046785

    Compositions and methods for treatment of diabetic macular edema

    Takeda Pharmaceutical Company Limited · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  3. US 11046959

    Compositions comprising TALENs and methods of treating HIV

    THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  4. US 11046941

    Methods of generating nucleic acid fragments

    The Regents of the University of California · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  5. US 11046730

    Antimicrobial compositions

    The Regents of the University of California · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  6. US 11046709

    Fused 1,4-diazepines as BET bromodomain inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  7. US 11046752

    Serpin fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  8. US 11046710

    Sulfonamide compounds

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  9. US 11046701

    Salt of cetagliptin, preparation method thereof, pharmaceutical composition, and use thereof

    CGeneTech (Suzhou, China) CO., Ltd. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  10. US 11046690

    Pyridazinones and methods of use thereof

    Goldfinch Bio, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  11. US 11046703

    Small molecule MDM2 protein degraders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  12. US 11046649

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase

    The Board of Regents of the University of Texas System · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  13. US 11046650

    Deuterated compounds and uses thereof

    Aldeyra Therapeutics, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  14. US 11045556

    Devices, compositions and related methods for accelerating and enhancing bone repair

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  15. US 11045555

    Pathogen-specific cargo delivery and diagnostic platform based on mesoporous silica nanoparticles

    The Regents of the University of California · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  16. US 11045535

    Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

    Inovio Pharmaceuticals, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  17. US 11045522

    Glucagon-like peptide 1 receptor agonists and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  18. US 11045549

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  19. US 11045482

    Use of glucocorticoid receptor modulators in the treatment of catecholamine-secreting tumors

    Corcept Therapeutics Incorporated · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  20. US 11045466

    Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same

    Platform Brightworks Two, Ltd. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  21. US 11045425

    Method of encapsulating pancreatic islet cells introduced to siRNA against PHLDA3

    KURARAY CO., LTD. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  22. US 11045472

    Quinazoline-pyridine derivatives for the treatment of cancer-related disorders

    Arcus Biosciences, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  23. US 11045478

    Salts of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  24. US 11045504

    Compositions and methods for treatment of cancer using bacteria

    Decoy Biosystems, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.